View profile

FarmaKology Newsletter - Issue #3

Would you like to submit an article or some interesting news? Send whatever you have to "abdul@farmak
FarmaKology Newsletter - Issue #3
By Abdul Menum Ali • Issue #3 • View online
Would you like to submit an article or some interesting news? Send whatever you have to “abdul@farmakology.com”, and happy to have it featured on our newsletter.

News
Eli Lilly and ImmuNext, a developer of immunotherapy compounds for cancer and autoimmune diseases, announced a global licensing and research collaboration worth up to $605 million focused on studying a preclinical novel target that could lead to potential new treatments for autoimmune diseases by regulating immune cell metabolism.
 Women with dense breasts who get mammograms must be told of their higher risk for breast cancer under new rules proposed Wednesday by the U.S. Food and Drug Administration.
Research
Podcast
Investor-State Arbitration And “Alternative Facts” In Pharmaceutical Marketing Jaharis Podcast On Health & IP podcast
Job Opportunities
Video
Reimagining pharmaceutical innovation | Thomas Pogge at TEDxCanberra
Reimagining pharmaceutical innovation | Thomas Pogge at TEDxCanberra
Did you enjoy this issue?
Abdul Menum Ali

FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "abdul@farmakology.com".

If you don't want these updates anymore, please unsubscribe here
If you were forwarded this newsletter and you like it, you can subscribe here
Powered by Revue